Metabolic research
A peptide encoded by mitochondrial DNA that appears to act as a metabolic signal between mitochondria and the rest of the cell.
MOTS-c is unusual in that it is encoded not by the nuclear genome but by mitochondrial DNA — a small class of peptides that appear to let mitochondria communicate their status to the rest of the cell. It was identified relatively recently and has drawn attention because the signal it sends looks a great deal like the one exercise sends.
MOTS-c activates AMPK, the cell's energy-sensing switch — the same pathway exercise and caloric restriction activate. When AMPK turns on, cells shift toward burning fuel and away from storing it, and glucose uptake improves. The interesting claim is that MOTS-c may be part of how exercise produces its metabolic benefits, which is also why it should be regarded as a supplement to training rather than a replacement for it.
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial 12S rRNA region. It activates the AMPK pathway, promoting glucose uptake and fatty acid oxidation, and influences the folate-methionine cycle affecting purine biosynthesis. Under metabolic stress it translocates to the nucleus and regulates stress-response gene expression, including antioxidant response elements. Effects on skeletal muscle insulin sensitivity and mitochondrial biogenesis are the most consistently reported.
Metabolic changes are not perceptible day to day. If it works as hypothesized, the readouts are laboratory values — fasting glucose, insulin, HbA1c — over months, not sensations over days. Anyone reporting a dramatic acute effect is likely reporting something else.
Every page on this site includes this section. If a source only tells you what something does, you are reading marketing.
Human safety data is minimal because controlled human studies are minimal. No significant adverse effects have been reported in animal work. Not FDA- or EMA-approved. Anyone on glucose-lowering medication should treat additive hypoglycemia as a real consideration and involve their prescriber. Not appropriate during pregnancy or breastfeeding.
Third-party purity testing with a batch-matched certificate of analysis. Given that the intended effects are invisible without labs, verification of what is in the vial matters more, not less.
It activates a pathway exercise also activates, which has led to that description. It is not equivalent to exercise, which produces many effects through many mechanisms.
Largely observational — level correlations with fitness and metabolic health. Controlled trials of administration are lacking.
The animal data shows protection against diet-induced obesity. That has not been demonstrated in humans, and it is not comparable to approved weight-loss medications.
General education only goes so far. If you want help deciding whether this is relevant to your goals, history, and current labs, schedule a consultation with the Bearing team.
Request a Consultation